ClinicalTrials.gg
Active, not recruitingNCT07902167Updated Oct 28, 2026

Evaluating the Efficacy and Safety of a New Laparoscopic Non-mesh Hernia Needle Set Designed for Indirect Inguinal Hernia

An interventional study of non-mesh inguinal hernia needle and conventional needle set in Inguinal Hernia, Without Mention of Obstruction or Gangrene, sponsored by Chang Gung Memorial Hospital. Active, not recruiting at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Treatment

Updated Oct 28, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective, single-blinded and randomized clinical trial, and will be conducted at Chang Gung Memorial Hospital Chiayi branch in Taiwan.

  1. Why is this study being done? Inguinal hernia is a common condition in adults. It can be classified into different types, and more than half of adult inguinal hernias are belonged to the "indirect" type.

    Traditionally, inguinal hernias are repaired with artificial mesh in adults. Since 2018, we use the laparoscopy-assisted percutaneous internal ring suture (PIRS), which has been proofed to be safe and effectiveness in repairing the pediatric indirect inguinal hernia, to treat the adult indirect inguinal hernias. More than 150 adult patients were treated by using this method with good results and low recurrence rate.

    However, conventional needles for the pediatric group are too short and weak to operate on the adult group. Now there is a new device, laparoscopic non-mesh hernia needle set, designed specifically for adults. We would like to evaluate whether this new device can: (1) Shorten the operation time; (2) Reduce postoperative pain; (3) Maintain a low recurrence rate

  2. What will happen to the participants

The participants, whose hernia confirmed to be the indirect type under laparoscopic inspection, would be randomly assigned to one of two groups:

(1) The control group: using conventional needle set for PIRS; (2) The experimental group: using laparoscopic non-mesh hernia needle set for PIRS.

Both groups would undergo the same surgical method except the needle devices. For the participants with inguinal hernias other than the indirect type, an adequate mesh repair be performed according to the Guideline of Hernia Surg (Hernia. 2018; 22(1): 17-18)

After surgery, three follow-up visits within six months would be arranged to all participants. Each visit will take about one hour. During these visits, we will:

(1) Record about recovery and pain conditions; (2) Check surgical wound; (3) Evaluate whether the hernia has recurred.

3. What are the possible complications? The risks of surgery are similar whether the participants join the study or not. Possible complications include: (1) Postoperative pain; (2) Hernia recurrence; (3) Wound infection; (4) Bruising or bleeding under the skin at the needle site

This study will help us to determine whether the new needle set could decrease the complication rate.

4. Participation in this study is completely voluntary. For the patients unwilling to participate this study, they will receive the standard procedures at present, including: (1) Open hernia repair with mesh, Lichtenstein method. (2) Laparoscopic hernia repair with mesh, TEP or TAPP. (3) Laparoscopic repair using the conventional hernia needle

Read the detailed description

Hernia, a common human disease, is defined as any organ or tissue leaving its normal location via congenital or acquired weak point, defect or fissure. Hernia frequently develops in inguinal (inguinal hernia), femoral (femoral hernia), umbilical (umbilical hernia), incision (incisional hernia) or diaphragmatic areas (diaphragmatic hernia).

Inguinal hernia accounts for more than 90% of all hernia. It is estimated 27% male and 3% female would be bothered by the inguinal hernia throughout the life. There were about 30 thousands of surgeries for hernia in Taiwan, and about 20 millions of surgeries for hernia worldwide annually. Inguinal hernia is classified into direct and indirect type. When testes passed through the inguinal canals into the scrotum before or after birth, the internal ring of inguinal canal would close gradually. Indirect type of inguinal hernia is abdominal organs or tissues enter the inguinal canal due to non-obliteration of internal ring. When inguinal hernia develops, one protruding mass would be seen on the groin area, and the patient feel pain and swelling. If the hernia could not be reduced spontaneously, the organ/tissue in the hernia sac would undergo blood supply disturbance, and organ/tissue necrosis, bowel perforation, even death follows. Surgery is usually suggested if one patient is diagnosed with inguinal hernia.

Open herniorrhaphy, which ligating the internal ring in the pre-peritoneal layer and then removing the hernia sac, is used to manage the indirect type of inguinal hernia traditionally. Incidence of inguinal hernia in children is about 5-6%, and almost is indirect type. Most patients are newborn to 6 years old. In 2006, Dr. Patkowski published percutaneous internal ring suture (PIRS) under laparoscopy. In PIRS the inner ring opening is closed by suture line in the pre-peritoneal layer under single-port laparoscopy. The hernia sac is remained without removal. It differs from the open herniorrhaphy is that the knots will tie the peritoneal layer and musculo-fascial layer at the same time, and patients were more painful after surgery. After 20-year observations, there was little difference found in the operation time and hernia recurrence rate between the open herniorrhaphy and PIRS. Surgical scars were smaller after PIRS, and it made PIRS being the routine surgery for indirect inguinal hernia in several children's hospitals in the America and Europe. In our hospital, there were more than 300 children with indirect inguinal hernia underwent single port laparoscopic PIRS since 2016. The operation time was less than 20 minutes in average. These children did not need admission, their recovery time was shorter, and the hernia recurrence rate was zero.

In adults, their inguinal hernia could be indirect, direct even mixed types. Inguinal hernia typing in adults often is not confirmed actually before surgery, yet the problem could be resolved during laparoscopy. Traditionally the main surgical method was to repair the inguinal hernia with mesh in the Hesselbach's triangle regardless of hernia type. The method could not satisfy every patient's requirement, and the overall hernia recurrence rate is 30-50%. In fact, 67-82% of adult cases with inguinal hernia belonged to the indirect type according to the published researches. Therefore, we thought single port laparoscopic PIRS could be utilized in adults also. In past 6 years, more than 100 adults underwent single port laparoscopic PIRS at our hospital for their indirect inguinal hernia. Hernia recurrence and chronic pain rate were 5%.

There is one new inguinal ring repair needle set developed recently, and which is suitable for single-port laparoscopic hernia surgery. The needle set is composed of puncture needle and suture guide needle. The puncture needle is composed of outer and inner sheath, and it can easily puncture and peel off the tissue. When the puncture needle arrives the inner ring of inguinal canal, removing the inner sheath, and outer sheath is left in the musculo-fascial layer. The suture guide needle is inserted into the outer sheath to tie and close the inner ring. The knot will naturally penetrate the muscular layer and stay on the peritoneal layer. In general, this hernia needle set can solve the inconvenience during the surgery and post-operative pain of patients.

This is a single-blind and randomized study to evaluate the safety and efficacy of the new inguinal needle set in managing the adults' indirect inguinal hernia.

  • Trial period: Two years.
  • Grouping: Divided into control and study group (sample size: 48 cases more than 18 years old in each group)
  • Random sampling: participants will be randomized equally to receive ready-made or new needle set for inguinal hernia.
  • Control group: Patients with indirect inguinal hernia and undergoing laparoscopic percutaneous internal ring suture via ready-made needle set.
  • Trial period: 2025-05-01 to 2027-04-30.
  • Follow-up period after surgery: six months.
  • Test execution location: Chang Gung Memorial Hospital at Chiayi, Taiwan.
  • Belonged to single center trial.
  • Confidentiality of subject information: If the medical records would be used for reports and analysis, the subjects will be identified with codes and personal informations will be removed.
  • Medical records would be used: (1) basic data: age, body height, body weight, BMI, hernia side, obliteration of the contralateral processus vaginalis, operation time, hospitalization days; (2) out-patient department follow up: post-operational pain severity and duration evaluated by Mankoski Pain Scale, analgesics kinds and frequencies, days for wound recovery, days for recovery of daily activities evaluated by Mankoski Pain Scale , hernia recurrence at the operational side.
  • The primary endpoint: post-operational pain score
02

Conditions studied

  • Inguinal Hernia, Without Mention of Obstruction or Gangrene
03

In context

Hernia, Inguinal

543 studies on the registry are indexed under Hernia, Inguinal; 92 are open to participants now.

This study's planned enrollment of 96 is close to the median of 90 across 395 interventional studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,096 studies on the registry; 239 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participant is willing and able to give written for participation in the trial.
  • Adults (more than 18 years old) with inguinal hernia.
  • Do not want to undergo traditional open hernia surgery, but willing to undergo single-port laparoscopy to determine the hernia type.
  • For the indirect hernia, the participant is willing to undergo percutaneous internal ring suture by using either the ready-made or neoteric needle set decided by us randomly.
  • If employees or students of the study institution are considered for participation, they may be enrolled only if all of the following conditions are met:

    1. They satisfy all inclusion criteria specified in this study protocol.
    2. The investigator and research personnel involved in recruitment are not the participant's direct supervisor, instructor, or evaluator, and have no responsibility for assessing the participant's academic, employment, or professional performance.
    3. Recruitment is conducted in a manner that minimizes the possibility of coercion or undue influence. Participants shall not be recruited through individual solicitation by their supervisors, instructors, or evaluators.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women.
  • Obesity: (BMI) ≧35.
  • Recurrent hernia after any hernia surgery.
  • Insufficient level of language to understand all study requirements in opinion of the investigators.
  • Hydroceles with multiple septations and complex anatomy.
  • Incarcerated or strangulated hernias.
  • Known connective tissue disorders (e.g., Loeys-Dietz, Marfan syndrome).
  • High bleeding tendency during surgery.
  • Technical conversion triggers: large hernias, edema, poor visualization.
  • Severe cardiopulmonary compromise.
  • Extensive intra-abdominal adhesions (e.g., from prior surgeries or infections).
  • Allergy to the materials of the medical devices used in this study (such as stainless steel and suture materials).
  • Patients asked for mesh repair for their inguinal hernia initially.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
96 participants (estimated)

Study arms

  • Experimental
    Experimental

    non-mesh inguinal needle set

    Device: non-mesh inguinal hernia needle

  • Active comparator
    Control

    conventional needle set

    Device: conventional needle set

  • No intervention
    Additional

    enrolled patients without indirect inguinal hernia

Interventions

  • Devicenon-mesh inguinal hernia needle

    Non-mesh inguinal hernia needle is used for indirect inguinal hernia repair by laparoscopy. It is composed of puncture needle and suture needle.

  • Deviceconventional needle set

    Conventional needle set is used traditionally for percutaneous internal ring suture in Chang Gung Memorial Hospital at Chiayi, Taiwan.

06

What researchers measure

Primary outcomes

  1. post operational pain

    Evaluated by Mankoski Pain Scale (score 0-10, zero is equivalent to no pain and 10 indicates the worst possible pain) on the operation day and one week after surgery, and recording frequency and kinds of analgesics used after surgery by charts

    Time frame: From enrollment to the end of treatment at 24 weeks

Secondary outcomes

  1. Operation time

    The operation time, measured in minutes, is defined as the time elapsed from insertion of the trocar through the umbilicus to its removal from the umbilicus at the end of the operation.

    Time frame: During the surgery

  2. Time to resumption of daily activities

    The number of days from surgery until the patient resumes usual daily activities, including work, exercise, and household activities.

    Time frame: From enrollment to the end of treatment at 24 weeks

  3. Ipsilateral inguinal hernia recurrence rate within six months after surgery

    The proportion of patients who develop recurrent inguinal hernia on the operated side within six months after surgery. The recurrence rate will be calculated as the number of patients with recurrence divided by the total number of patients evaluated for recurrence, multiplied by 100%.

    Time frame: From enrollment to the end of treatment at 24 weeks

  4. Wound infection rate

    The proportion of patients who develop a surgical wound infection following surgery during the prespecified follow-up period. The wound infection rate will be calculated as the number of patients with a wound infection divided by the total number of patients evaluated for wound infection, multiplied by 100%.

    Time frame: From enrollment to the end of treatment at 24 weeks

07

Study locations

1 site
08

References and documents

Publications

  • Wang SH, Lee CY, Hsieh WC, Yen JB, Tseng IM, Wong CH, Ho DR. Tailored treatment of female indirect inguinal hernias by using single-port laparoscopic percutaneous internal ring suture: a comparison between children and adults. Hernia. 2024 Aug;28(4):1365-1372. doi: 10.1007/s10029-024-03055-3. Epub 2024 May 22. PubMed 38775981 ↗
  • Wang SH, Yen JB, Hsu SL. The application of single-port laparoscopic percutaneous internal ring suture for the management of indirect inguinal hernia in female adults. Sci Rep. 2020 Oct 1;10(1):16244. doi: 10.1038/s41598-020-73171-4. PubMed 33004858 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Apr 2027, 13 months after the start.

Of 177 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 13 months is below that.

Counting every sponsor, half of 186 studies reached it within 19 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 2, 2026
First posted
Oct 28, 2026
StartActual
Mar 4, 2026
Primary completionEst.
Apr 30, 2027
CompletionEst.
Apr 30, 2027
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07902167
Responsible party
Sponsor
First posted
Oct 28, 2026
Start date
Mar 4, 2026
Primary completion
Apr 30, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Oct 28, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion